305 related articles for article (PubMed ID: 22503878)
1. Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Delattre IK; Musuamba FT; Jacqmin P; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq P
Clin Biochem; 2012 Jul; 45(10-11):780-6. PubMed ID: 22503878
[TBL] [Abstract][Full Text] [Related]
2. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
Delattre IK; Musuamba FT; Verbeeck RK; Dugernier T; Spapen H; Laterre PF; Wittebole X; Cumps J; Taccone FS; Vincent JL; Jacobs F; Wallemacq PE
Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
[TBL] [Abstract][Full Text] [Related]
5. Can changes in renal function predict variations in β-lactam concentrations in septic patients?
Casu GS; Hites M; Jacobs F; Cotton F; Wolff F; Beumier M; De Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2013 Nov; 42(5):422-8. PubMed ID: 23993066
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira J; Póvoa P
Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
[TBL] [Abstract][Full Text] [Related]
7. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
8. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
Wolff F; Deprez G; Seyler L; Taccone F; Hites M; Gulbis B; Vincent JL; Jacobs F; Cotton F
Talanta; 2013 Jan; 103():153-60. PubMed ID: 23200371
[TBL] [Abstract][Full Text] [Related]
9. β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
Jacobs A; Taccone FS; Roberts JA; Jacobs F; Cotton F; Wolff F; Creteur J; Vincent JL; Hites M
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987138
[TBL] [Abstract][Full Text] [Related]
10. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
[TBL] [Abstract][Full Text] [Related]
11. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
[TBL] [Abstract][Full Text] [Related]
12. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
[TBL] [Abstract][Full Text] [Related]
13. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
[TBL] [Abstract][Full Text] [Related]
14. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
[TBL] [Abstract][Full Text] [Related]
15. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
17. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
Boidin C; Moshiri P; Dahyot-Fizelier C; Goutelle S; Lefeuvre S
Anaesth Crit Care Pain Med; 2020 Feb; 39(1):87-109. PubMed ID: 31513935
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
20. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
